Gloria J Hong1, Jagger C Koerner1, Marguerite C Weinert2, Sandra S Stinnett1, Sharon F Freedman1, David K Wallace3, J Wayne Riggins4, Keith J Gallaher5, S Grace Prakalapakorn6. 1. Department of Ophthalmology, Duke University, Durham, North Carolina. 2. Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts. 3. Department of Ophthalmology, Indiana University, Indianapolis, Indiana. 4. Department of Neonatology, Cape Fear Valley Medical Center, Fayetteville, North Carolina; Cape Fear Eye Associates, Fayetteville, North Carolina. 5. Department of Neonatology, Cape Fear Valley Medical Center, Fayetteville, North Carolina. 6. Department of Ophthalmology, Duke University, Durham, North Carolina. Electronic address: grace.prakalapakorn@duke.edu.
Abstract
PURPOSE: To quantitatively compare retinal vascular characteristics over time in eyes eventually treated versus not treated for retinopathy of prematurity (ROP), using ROPtool analysis of narrow-field retinal images. METHODS: This longitudinal study used prospectively collected narrow-field retinal images of infants screened for ROP, prior to treatment, if needed. Images were analyzed using a methodology that combines quadrant-level measures from several images of the same eye. For the longitudinal analysis, one examination per postmenstrual age (PMA) was included per eye. We compared the following ROPtool indices and their change per week between eyes eventually treated versus not treated for ROP: tortuosity index (TI), dilation index (DI), sum of adjusted indices (SAI), and tortuosity-weighted plus (TWP). Analysis was performed on three levels: eye (mean value/eye), quadrant (highest quadrant value/eye), and blood vessel (highest blood vessel value/eye). RESULTS: Of 832 examinations (99 infants), 745 images (89.5%) had 3-4 quadrants analyzable by ROPtool. On the eye level, ROPtool indices differed between eyes eventually treated versus not treated at PMA of 33-35 and 37 weeks for TI, SAI, and TWP, and at PMA of 33-34 and 37 weeks for DI (P ≤ 0.0014), and change per week differed between eyes eventually treated versus not treated only for SAI at PMA of 32 weeks (P < 0.001). CONCLUSIONS: Quantitative analysis of retinal vascular characteristics using ROPtool can help predict eventual need for treatment for ROP as early as 32 weeks PMA. ROPtool index values were more useful than change in these indices to predict eyes that would eventually need treatment for ROP.
PURPOSE: To quantitatively compare retinal vascular characteristics over time in eyes eventually treated versus not treated for retinopathy of prematurity (ROP), using ROPtool analysis of narrow-field retinal images. METHODS: This longitudinal study used prospectively collected narrow-field retinal images of infants screened for ROP, prior to treatment, if needed. Images were analyzed using a methodology that combines quadrant-level measures from several images of the same eye. For the longitudinal analysis, one examination per postmenstrual age (PMA) was included per eye. We compared the following ROPtool indices and their change per week between eyes eventually treated versus not treated for ROP: tortuosity index (TI), dilation index (DI), sum of adjusted indices (SAI), and tortuosity-weighted plus (TWP). Analysis was performed on three levels: eye (mean value/eye), quadrant (highest quadrant value/eye), and blood vessel (highest blood vessel value/eye). RESULTS: Of 832 examinations (99 infants), 745 images (89.5%) had 3-4 quadrants analyzable by ROPtool. On the eye level, ROPtool indices differed between eyes eventually treated versus not treated at PMA of 33-35 and 37 weeks for TI, SAI, and TWP, and at PMA of 33-34 and 37 weeks for DI (P ≤ 0.0014), and change per week differed between eyes eventually treated versus not treated only for SAI at PMA of 32 weeks (P < 0.001). CONCLUSIONS: Quantitative analysis of retinal vascular characteristics using ROPtool can help predict eventual need for treatment for ROP as early as 32 weeks PMA. ROPtool index values were more useful than change in these indices to predict eyes that would eventually need treatment for ROP.
Authors: Lili Grunwald; Monte D Mills; Keegan S Johnson; Karen A Karp; Graham E Quinn; Gui-Shuang Ying; Juan E Grunwald Journal: Am J Ophthalmol Date: 2009-03-16 Impact factor: 5.258
Authors: Gil Binenbaum; Edward F Bell; Pamela Donohue; Graham Quinn; James Shaffer; Lauren A Tomlinson; Gui-Shuang Ying Journal: JAMA Ophthalmol Date: 2018-09-01 Impact factor: 7.389
Authors: Devon H Ghodasra; Atiporn Thuangtong; Karen A Karp; Gui-Shuang Ying; Monte D Mills; Clare A Wilson; Alistair R Fielder; Jeffery Ng; Graham E Quinn Journal: J AAPOS Date: 2012-10 Impact factor: 1.220
Authors: S Grace Prakalapakorn; Sandra S Stinnett; Sharon F Freedman; David K Wallace; J Wayne Riggins; Keith J Gallaher Journal: J Perinatol Date: 2018-07-02 Impact factor: 2.521